Yi Shi

2.6k total citations
86 papers, 1.8k citations indexed

About

Yi Shi is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yi Shi has authored 86 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 19 papers in Cancer Research and 14 papers in Oncology. Recurrent topics in Yi Shi's work include RNA modifications and cancer (18 papers), RNA and protein synthesis mechanisms (12 papers) and RNA Research and Splicing (9 papers). Yi Shi is often cited by papers focused on RNA modifications and cancer (18 papers), RNA and protein synthesis mechanisms (12 papers) and RNA Research and Splicing (9 papers). Yi Shi collaborates with scholars based in China, United States and Taiwan. Yi Shi's co-authors include Rong Xiang, Xiang‐Lei Yang, Longlong Wang, Shuji Kishi, Yongjun Piao, Xiaoling Xu, Guangsen Fu, Na Wei, Zhongying Mo and Su Yeong Kim and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Yi Shi

80 papers receiving 1.7k citations

Peers

Countries citing papers authored by Yi Shi

Since Specialization

Citations

This map shows the geographic impact of Yi Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Shi more than expected).

Fields of papers citing papers by Yi Shi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Shi. The network helps show where Yi Shi may publish in the future.

Co-authorship network of co-authors of Yi Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Shi. A scholar is included among the top collaborators of Yi Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Shi. Yi Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of a Novel EGFR PROTAC Degrader against C797S Resistance Mutation with Potent Antitumor Efficacy in NSCLC Treatment 2025 ·Journal of Medicinal Chemistry ·Xiaoxue Wang, Cheng Wang, Yakun Ma, (unknown), Yi Shi, Shuang Yang, Jia Li, Yan Fan	0
2	Metabolic gatekeeper ACAD9 coordinates linoleic acid metabolism and redox homeostasis via mitochondrial complex I to drive ovarian cancer progression 2025 ·Cancer Letters ·Jia Li, Jie Shi, Jiaji Ding, (unknown), (unknown), Ying Bai, Shuo Wang, (unknown), Yanan Chen, Yanhua Liu, Weifeng Ding, Yongjun Piao, Fan Yan, Longlong Wang, Shuang Yang, Tong Li, Yi Shi	0
3	BICC1 drives pancreatic cancer stemness and chemoresistance by facilitating tryptophan metabolism 2024 ·Science Advances ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Jianming Li, Tiansuo Zhao, Xiuchao Wang, (unknown), (unknown), Song Gao, Shengyu Yang, Yi Shi, Jing Liu, Antao Chang, Chongbiao Huang, Jihui Hao	15
4	TRPC4 aggravates hypoxic pulmonary hypertension by promoting pulmonary endothelial cell apoptosis 2024 ·Free Radical Biology and Medicine ·(unknown), (unknown), (unknown), (unknown), Yi Shi, (unknown), Chang Zhou, Hong Yao, (unknown), Yu Fan, Lei Feng, (unknown), Guizhu Liu	6
5	USP51/PD‐L1/ITGB1‐deployed juxtacrine interaction plays a cell‐intrinsic role in promoting chemoresistant phenotypes in non‐small cell lung cancer 2023 ·Cancer Communications ·Jianjun Li, Xuechun Xiao, Yang Ou, Lixia Cao, Min Guo, (unknown), Zhaoyang Wang, Yuxin Liu, (unknown), Hang Wang, Peiqing Sun, Yi Shi, Guang Yang, Shuang Yang	23
6	Seryl-tRNA synthetase promotes translational readthrough by mRNA binding and involvement of the selenocysteine incorporation machinery 2023 ·Nucleic Acids Research ·Ze Liu, Justin Wang, Yi Shi, Brian A. Yee, (unknown), Qian Zhang, Jenq‐Chang Lee, Kuo‐I Lin, Andrew H.‐J. Wang, Susan L. Ackerman, G Yeo, Haissi Cui, (unknown)	10
7	COMMD3-Mediated Endosomal Trafficking of HER2 Inhibits the Progression of Ovarian Carcinoma 2022 ·Molecular Cancer Research ·(unknown), (unknown), (unknown), (unknown), (unknown), Jie Yan, Jiayi Wu, (unknown), Longlong Wang, Rong Xiang, Yi Shi, Xuan Qin, Shuang Yang	3
8	Triple-Wavelength Lasing with a Stabilized β-LaBSiO₅:Nd³⁺ Crystal 2022 ·Journal of the American Chemical Society ·Lingyun Li, (unknown), Yi Shi, Zhong‐Zhen Luo, Guoqiang Wang, Xin‐Xiong Li, Bingxuan Li, Lizhen Zhang, Yi Yu, Ya‐Nan Feng, Chengkai Yang, Yan Yu, Kenneth R. Poeppelmeier	20
9	Glucose-sensitive acetylation of Seryl tRNA synthetase regulates lipid synthesis in breast cancer 2021 ·Signal Transduction and Targeted Therapy ·Jin Zhao, (unknown), Xiaoyu Li, Jie Yan, Gengyi Zou, Longlong Wang, Xiru Li, Ze Liu, Rong Xiang, (unknown), Yi Shi	20
10	A systematic CRISPR screen reveals an IL-20/IL20RA-mediated immune crosstalk to prevent the ovarian cancer metastasis 2021 ·eLife ·Jia Li, Xuan Qin, Jie Shi, Xiaoshuang Wang, Tong Li, (unknown), Xiaosu Chen, Yujia Zhao, Jiahao Han, Yongjun Piao, Wenwen Zhang, Pengpeng Qu, Longlong Wang, Rong Xiang, Yi Shi	17
11	Nucleotide de novo synthesis increases breast cancer stemness and metastasis via cGMP-PKG-MAPK signaling pathway 2020 ·PLoS Biology ·(unknown), Xiaoshuang Wang, Xiaoyu Li, Guang‐wei Xu, (unknown), Jiayi Wu, Yongjun Piao, Yi Shi, Rong Xiang, Longlong Wang	87
12	Phosphorylation of seryl-tRNA synthetase by ATM/ATR is essential for hypoxia-induced angiogenesis 2020 ·PLoS Biology ·Yi Shi, Ze Liu, Qian Zhang, (unknown), Zhongying Mo, Shuji Kishi, Xiang‐Lei Yang	23
13	Screening Test of Oat Varieties in Northern Shanxi 2020 ·(unknown), (unknown), Yi Shi	0
14	Discovery of 12O—A Novel Oral Multi-Kinase Inhibitor for the Treatment of Solid Tumor 2020 ·Molecules ·Yan Fan, Zhi Huang, Xiaoshuang Wang, Yakun Ma, Yongtao Li, Shengyong Yang, Yi Shi	4
15	The effect of anastomotic angle and diameter ratio on flow field in the distal end-to-side anastomosis 2019 ·Proceedings of the Institution of Mechanical Engineers Part H Journal of Engineering in Medicine ·Zhaomiao Liu, (unknown), (unknown), Yipeng Qi, Yan Pang, Yi Shi	7
16	Seryl tRNA synthetase cooperates with POT1 to regulate telomere length and cellular senescence 2019 ·Signal Transduction and Targeted Therapy ·Yingxi Li, Xiyang Li, Mei Cao, (unknown), Jie Yan, Ze Liu, Rongcun Yang, Xu Chen, Peiqing Sun, Rong Xiang, Longlong Wang, Yi Shi	23
17	Phosphodiesterase 3A Represents a Therapeutic Target that Drives Stem Cell–like Property and Metastasis in Breast Cancer 2019 ·Molecular Cancer Therapeutics ·Na Hao, Wenzhi Shen, Renle Du, Shan Jiang, Junyong Zhu, Yanan Chen, Chongbiao Huang, Yi Shi, Rong Xiang, Yunping Luo	22
18	TGIF2 promotes the progression of lung adenocarcinoma by bridging EGFR/RAS/ERK signaling to cancer cell stemness 2019 ·Signal Transduction and Targeted Therapy ·Renle Du, Wenzhi Shen, Yi Liu, Wenjuan Gao, Wei Zhou, Jun Li, Shuangtao Zhao, Chong Chen, Yanan Chen, Yanhua Liu, Peiqing Sun, Rong Xiang, Yi Shi, Yunping Luo	40
19	E6-induced selective translation of WNT4 and JIP2 promotes the progression of cervical cancer via a noncanonical WNT signaling pathway 2019 ·Signal Transduction and Targeted Therapy ·(unknown), Longlong Wang, (unknown), Ze Liu, Yongjun Piao, Jie Yan, Rong Xiang, Yuanqing Yao, Yi Shi	19
20	Association between fibrillin-1 gene exon 15 and 27 polymorphisms and risk of mitral valve prolapse. 2003 ·PubMed ·(unknown), Yi Shi, Yuan‐Man Hsu, Fuu Jen Tsai	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact